Chitosan Modification and Pharmaceutical/Biomedical Applications

Модификация хитозана и фармацевтические/биомедицинские применения
Bo Li, Ping Liu, Wenshui Xia, Jiali Zhang, Qinyuan Cheng, Talba Tahi, Wenxiu Gu
2010-06-25

D-Glucosaminic acidblood hemostasischitooligosaccharideschitosan modificationhypocholesterolemic effects
Chitosan has received much attention as a functional biopolymer for diverse applications, especially in pharmaceutics and medicine. Our recent efforts focused on the chemical and biological modification of chitosan in order to increase its solubility in aqueous solutions and absorbability in the in vivo system, thus for a better use of chitosan. This review summarizes chitosan modification and its pharmaceutical/biomedical applications based on our achievements as well as the domestic and overseas developments: (1) enzymatic preparation of low molecular weight chitosans/chitooligosaccharides with their hypocholesterolemic and immuno-modulating effects; (2) the effects of chitin, chitosan and their derivatives on blood hemostasis; and (3) synthesis of a non-toxic ion ligand--D-Glucosaminic acid from oxidation of D-Glucosamine for cancer and diabetes therapy.
1
Chemical and biological modification of chitosan is pursued to improve its aqueous solubility and in vivo absorbability for pharmaceutical and biomedical use.
2
Chitin, chitosan, and their derivatives exhibit effects on blood hemostasis, supporting investigation of their biomedical applications.
3
Enzymatic preparation of low-molecular-weight chitosans and chitooligosaccharides is associated with hypocholesterolemic and immunomodulatory effects.
4
Oxidation of D-glucosamine enables synthesis of the non-toxic ion ligand D-glucosaminic acid for potential cancer and diabetes therapy.

Chitosan and its chemically or biologically modified derivatives, including low-molecular-weight chitosans, chitooligosaccharides, and D-glucosaminic acid

Modification-dependent solubility, in vivo absorbability, biological effects, and pharmaceutical/biomedical applications, including hypocholesterolemic, immunomodulatory, hemostatic, anticancer, and antidiabetic activities

Publication Details
Publication Date
2010-06-25
Journal
Publisher
ISSN
Cited by
532
Access Type
Author Information
Authors
Bo Li
Ping Liu
Wenshui Xia
Jiali Zhang
Qinyuan Cheng
Talba Tahi
Wenxiu Gu
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%